Fri, May 26, 2017 | updated 04:48 PM IST

Non-invasive gene therapy could treat brain tumour

Updated: Jul 23, 2016 10:55 IST      
Non-invasive gene therapy could treat brain tumour

Washington, July 23 (ANI): A team of researchers at the University of Massachusetts Medical School, led by an Indian neuroscientist, has developed a non-invasive gene therapy to treat brain tumour.

Currently, treatment for brain tumour or Gliobastoma (GBM) involves surgery, followed by radiation and chemotherapy with temozolomide.

Still, complete surgical removal of tumour is nearly impossible, as these cells are also radio and chemotherapy resistant.

Thus, tumour recurs in a few months after surgery and finally causes death. Even with the best of treatment, only 3% patients survive up to five years.

One of the major difficulties to treat glioblastoma is the tumour cells are highly migratory and they travel long distances within the brain as single cell infiltrates and invades within other tissues.

These single cell infiltrations are difficult to detect in the MRI scan and also almost indistinguishable from healthy tissues in the brain. Thus, it is impossible to remove the tumour completely in a surgery.

Since the overall survival of a GBM patient post diagnosis is less than two years, medical scientists have been exploring therapeutic approaches to prevent recurrence of tumour.

According to a report appearing in the Indian Science Journal, a team of scientists led by Dwijit Guha Sarkar of University of Massachusetts Medical School researched the possibility of such an approach and found a systemic delivery approach of viral vector mediated gene therapy injection in the blood, with Interferon beta (IFNb) gene. IFNb is a cytokine secreted from cells upon viral infection and activates several genes downstream.

IFNb is a cytokine, which is a class of secreted proteins that play important immune functions in our body. IFNb is naturally secreted from our body cells as a part of immune protective mechanism when there is a viral infection. It can modulate ~300 other gene expressions downstream and can activate many biochemical pathways.

Interestingly, other than its role as immune-modulator, it has several anti-tumour functions. It can inhibit cancer cell division, prevents new blood vessel formation (angiogenesis) in tumour, can also sensitize some chemo-resistant tumour cells to some chemotherapeutic drugs.

"In search for a new therapeutic approach, in this study we examined (in a mouse model) a method of gene therapy. We have implanted highly invasive and aggressive human glioblastoma tumour cells in the mouse brain. We allowed it to graft and grow. Then we treated these animals with our new gene therapy approach. We have used adeno-associated viral vector (AAV) mediated interferon-beta (IFNb) gene therapy, GuhaSarkar told Indian Science Journal.

Gene therapy involves supplementing, silencing, correcting, or providing with genes having therapeutic benefit. Traditionally, gene therapy is a strategy most commonly being tested for treatment of single gene disorders, where a single non-functioning or bad (mutated) gene is responsible for the disease. Gene therapy strategy usually supplements the body with a good version of the gene or silences a gene producing toxic proteins. More recently, a new approach of gene therapy is also attempting to correct the bad gene by editing the genome - the complete set of genetic material present in a cell of a host organism, instead of just supplementing or silencing.

Scientists have tested different gene therapy approaches to treat cancers. But glioblastoma and many other cancers are often caused by abnormal functioning of multiple genes that involve a complex pathological mechanism, which is still be completely understood. So, simply supplementing, silencing or editing one gene is not sufficient to treat these cancers.

Therefore, scientists needed to take different approaches. One of them is to deliver some genes to the cancer cells, where the genes express proteins that can directly or through activating a drug can kill the same cancer cells that are producing that protein. Those genes are called "suicidal genes" as they kill the same cells where they are produced. If gene delivery can be done specifically and efficiently to the cancer cells, minimizing the suicidal gene transfer to the healthy normal cells, this approach could be promising. But often gene delivery to cancer cells is a very inefficient process and difficult to achieve specific targeting. Hence, only some cancer cells that receive the suicide genes die, but many cells escape the treatment, which causes recurrence of tumour.

"We found that this treatment was effective in a dose-responsive manner and an optimum dose could completely eliminate the highly invasive tumour from mouse brain and provided long term survival benefit. At the end of the study, we analyzed the brain microscopically using tissue and tumour staining where could not detect any remaining or recurring tumour in the treated animals, added Dr. GuhaSarkar. "We also found this intravenous delivery approach (injecting in the blood) was far superior to local treatment approach for treating a condition with multiple distant tumours."

GuhaSarkar said, the result of the current study is very exciting and demonstrates a promising new approach. But, there are a few more challenges that have to be addressed before moving on to human trials. One of them is that, these mice used for human tumour grafting were for obvious reasons immune-compromised, so they don't reject the human-origin cells. But body's immune system interacts with the tumour in a complex mechanism and plays important role in tumour prognosis. Moreover, IFNb as a molecule has immune-modulatory role when expressed in the species-matched host.

Human IFNb over-expression in human body can potentially have detrimental side effects unless expressed in a regulated manner. Hyper-activation of immune system by continuous expression of IFNb could also have possible toxic effects in the long term unless the expression can be switched off when it is not needed anymore. These issues have to be taken care of before this approach can be successfully replicated in human beings.

GuhaSarkar is an alumnus of the University of Calcutta and plan to take up post-doctoral research in Bose Institute, Kolkata after his current research under the guidance of Dr. Miguel Sena-Esteves at University of Massachusetts Medical School. (ANI)

23-year-old suffers severe heart attack due to smoking

Updated: May 26, 2017 16:01 IST     

New Delhi [India], May 26 (ANI): With several reasons attributing to a paradigm shift in the age groups suffering from heart attacks to younger age brackets, tobacco induced cardiac arrests rate as one of the topmost ones.

Full Story >>

New Delhi [India], May 26 (ANI): According to statistics, India has the third largest Muslim population in the world. The month of Ramadan is about to begin and a vast majority of this population will be fasting for a large number of days.

Full Story >>

New Delhi [India], May 26 (ANI): Looks like a ray of hope can be seen for the patients suffering from early stage oropharyngeal carcinoma (cancer of the mouth, neck and throat), in form of robotic surgery.

Full Story >>

Frequent recreational weed puts your mouth at risk

Updated: May 26, 2017 08:12 IST     

Washington D.C. [USA], May 26 (ANI): Frequent recreational use of cannabis, including marijuana, hashish, and hash oil, ups the risk of gum disease, a recent study has found.

Full Story >>

Washington D.C. [USA], May 25 (ANI): A study, presented at EuroCMR, says that chemotherapy-induced cardiomyopathy react more on men than women.

Full Story >>

New Delhi [India], May 25 (ANI): Envisioning a leap in emergency care, Aster DM Healthcare on Thursday launched its most novel and unique concept, the 'Aster Emergency' app, which will offer real-time interface between the patient in emergency and a GPS-enabled Aster 'Responder'.

Full Story >>

New Delhi [India], May 25 (ANI-BusinessWireIndia): Everyuth Naturals, a pioneer and a leading skincare brand known for its natural ingredients and effective products has announced the re-launch of its flagship product in the face wash category with-the new improved Everyuth Tulsi Turmeric Face Wash.

Full Story >>

New Delhi [India], May 25 (ANI): A Sutureless Valve Replacement surgery was recently performed on a 78 year old patient by Global Hospitals, Mumbai.

Full Story >>

Suicide rates among people with autism on rise

Updated: May 25, 2017 11:26 IST     

Washington D.C. [USA], May 25 (ANI): According to a recent study, suicide rates among autism patients have reached 'worryingly' high levels.

Full Story >>

Unhappy, less aware youth prone to alcohol addiction

Updated: May 25, 2017 10:36 IST     

Washington D.C. [USA], May 25 (ANI): Making youth aware of the harms of smoking and drinking could help them steer away from alcohol and cigarettes, suggests a recent study.

Full Story >>

London [UK], May 24 (ANI): Sleep is the easiest thing to forego by hardworking individuals. What we don't realize is, when sleep fails, one's health declines along with the quality of life.

Full Story >>

Washington D.C. [USA], May 24 (ANI): According to a recent study, adequate levels of Vitamin D combined with good sleep can help you manage chronic arthritis and back pain.

Full Story >>

Washington D.C. [USA], May 24 (ANI): You might consider yourself to be a recreational user but could be further along the road to drug addiction than you might have realized, a study suggests.

Full Story >>

Washington D.C. [USA], May 24 (ANI): A recent study shows a multi-protein biomarker blood test to detect breast cancer can potentially reduce use of biopsy up to 67percent.

Full Story >>

Childhood obesity results in early onset of arthritis

Updated: May 24, 2017 09:32 IST     

New Delhi [India], May 7 (ANI): Obesity, which is assuming epidemic proportions among children, is proving too much on their delicate bones and joints.

Full Story >>

Washington D.C. [USA], May 24 (ANI): A team of researchers has found that intestinal fungi, chronic liver damage, increase risk of death for the people with alcohol-related liver disease.

Full Story >>

Here's what dentists can tell about your health

Updated: May 23, 2017 16:46 IST     

Washington D.C. [USA], May 23 (ANI): A recent study has found that by using medical and dental records, researchers can identify what is the cause of disease and how the patients with certain diseases will respond to surgery, medication or other interventions.

Full Story >>

Trying to lose weight? Dieting may not help

Updated: May 23, 2017 15:08 IST     

Washington D.C. [USA], May 23 (ANI): Dieting has a little effect on losing weight, as a study finds that brain cells act as a trigger to prevent us burning calories when food is scarce.

Full Story >>

Washington D.C. [USA], May 23 (ANI): A study finds that late middle-aged people, with a family history and longer version of mitochondrial gene, encountered twice as much memory loss up to 10 years later as someone with a family history and a short version of the gene.

Full Story >>

New Delhi [India], May 22 (ANI): Global nutrition company Herbalife Nutrition undertook a survey on balanced nutrition in 12 markets across Asia Pacific and surveyed more than 6,000 consumers to understand eating habits, exercise and lifestyle habits among them.

Full Story >>